Tue, 15 Jul 2008 15:32:37 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.6 - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en-us 2006 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/endocrinology/endocrinologyalbumart_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Endocrinology no PeerView Press Please be sure to view the accompanying (PDF) file or full CME/CE information. In this activity, experts in the treatment of diabetes explore the use of incretin-based therapies in the management of this condition. An assessment of data from the 68th Scientific Sessions of the American Diabetes Association is featured. http://podcast.peerviewpress.com/Endocrinology/PA04206FCe020.mp3 http://podcast.peerviewpress.com/endocrinology/PA04206FCe020.mp3 Mon, 14 Jul 2008 15:27:46 -0400 Science no 00:33:35 diabetes, incretin, beta-cell, DPP-IV inhibitors, GLP-1, GIP, sitagliptin, exenatide, liraglutide, alogliptin PeerView Press Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA04206FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA04206FCCMEinfo.pdf Mon, 14 Jul 2008 15:27:45 -0400 Science no 00:00:00 diabetes, incretin, beta-cell, DPP-IV inhibitors, GLP-1, GIP, sitagliptin, exenatide, liraglutide, alogliptin PeerView Press Please be sure to view the accompanying (PDF) file or full CME/CE information. In this activity, an expert in the treatment of diabetes investigates the importance of addressing the many cardiometabolic risk factors that are present in patients with type 2 diabetes. The activity also features an analysis of the impact of newer antidiabetic agents, including incretin mimetics and DPP-IV inhibitors, on improving a number of these risk factors. http://podcast.peerviewpress.com/Endocrinology/PA04817FCn186.mp3 http://podcast.peerviewpress.com/endocrinology/PA04817FCn186.mp3 Wed, 02 Jul 2008 14:02:06 -0400 Science no 00:24:31 Diabetes, exenatide, sitagliptin, 68th Scientific Sessions of the American Diabetes Association, GLP-1 receptor agonists, DPP-IV inhibitors, obesity, cardiovascular disease PeerView Press Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA04817FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA04817FCCMEinfo.pdf Wed, 02 Jul 2008 14:02:04 -0400 Science no 00:00:00 Diabetes, exenatide, sitagliptin, 68th Scientific Sessions of the American Diabetes Association, GLP-1 receptor agonists, DPP-IV inhibitors, obesity, cardiovascular disease PeerView Press Please be sure to view the accompanying (PDF) file or full CME/CE information. In this CME activity, an expert in the treatment of male hypogonadism discusses the diagnosis and treatment of this condition. Testosterone replacement therapy and the different treatment modalities are also reviewed. http://podcast.peerviewpress.com/Endocrinology/PA03527FCp117.mp3 http://podcast.peerviewpress.com/endocrinology/PA03527FCp117.mp3 Wed, 05 Sep 2007 16:13:42 -0400 Science no 00:32:09 Male hypogonadism, testosterone, testosterone replacement therapy, TRT, delivery systems, transdermal patches, buccal system, testosterone gel, intramuscular injections, subcutaneous pellets, metabolic syndrome PeerView Press Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA03537FCp117.pdf http://podcast.peerviewpress.com/endocrinology/PA03527FCCMEinfo.pdf Wed, 05 Sep 2007 16:12:42 -0400 Science no 00:00:00 Male hypogonadism, testosterone, testosterone replacement therapy, TRT, delivery systems, transdermal patches, buccal system, testosterone gel, intramuscular injections, subcutaneous pellets, metabolic syndrome PeerView Press Please be sure to view the accompanying (PDF) file or full CME/CE information. In this CME activity, an expert in the management of type 2 diabetes discusses recent data on current and emerging glucagon-like peptide (GLP-1) mimetics and dipeptidyl peptidase IV (DPP-IV) inhibitors. http://podcast.peerviewpress.com/Endocrinology/PA03868FCn166.mp3 http://podcast.peerviewpress.com/endocrinology/PA03868FCn166_2.mp3 Fri, 03 Aug 2007 16:17:47 -0400 Science no 00:19:40 Diabetes, T2DM, insulin resistance, glucagon-like peptide-1, GLP-1, DPP-IV inhibitors, sulfonylureas, meglitinides, metformin, thiazolidinediones, insulin, exenatide, liraglutide, sitagliptin, vildagliptin, alogliptin, SYR-322, BI 1356, ABT-279 PeerView Press Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA03868FCn166.pdf http://podcast.peerviewpress.com/endocrinology/PA03868FCn166.pdf Fri, 03 Aug 2007 16:17:41 -0400 Science no 00:00:00 Diabetes, T2DM, insulin resistance, glucagon-like peptide-1, GLP-1, DPP-IV inhibitors, sulfonylureas, meglitinides, metformin, thiazolidinediones, insulin, exenatide, liraglutide, sitagliptin, vildagliptin, alogliptin, SYR-322, BI 1356, ABT-279 PeerView Press Please be sure to view the accompanying (PDF) file or full CME/CE information. In this CME activity, experts in the treatment of diabetes present recent data on the efficacy and safety of therapies used in the management of this disease. Recent data on the pathophysiology of the development of diabetes will be addressed. http://podcast.peerviewpress.com/Endocrinology/PA03836FCr313.mp3 http://podcast.peerviewpress.com/endocrinology/PA03836FCr313.mp3 Tue, 26 Jun 2007 15:45:04 -0400 Science no 00:29:24 Diabetes, T2DM, insulin resistance, glucagon-like peptide-1, GLP-1, DPP-IV inhibitors, sulfonylureas, meglitinides, metformin, carbohydrate absorption inhibitors, thiazolidinediones, insulin, pramlintide, exenatide, liraglutide, ZP10, sitagliptin PeerView Press Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA03836FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA03836FCCMEinfo.pdf Tue, 26 Jun 2007 15:44:31 -0400 Science no 00:00:00 Diabetes, T2DM, insulin resistance, glucagon-like peptide-1, GLP-1, DPP-IV inhibitors, sulfonylureas, meglitinides, metformin, carbohydrate absorption inhibitors, thiazolidinediones, insulin, pramlintide, exenatide, liraglutide, ZP10, sitagliptin PeerView Press Please be sure to view the accompanying (PDF) file or full CME/CE information. In this CME/CE activity, experts in the management of diabetes and cardiovascular disease discuss recent data on the management of cardiovascular risk in people with type 2 diabetes. New insights on the etiology and diagnosis of cardiovascular disease in this population are reviewed. The current guidelines for management of CV events are highlighted. http://podcast.peerviewpress.com/Endocrinology/PA03563FCr259.mp3 http://podcast.peerviewpress.com/endocrinology/PA03563FCr259.mp3 Thu, 08 Mar 2007 16:29:54 -0500 Science no 00:33:00 diabetes, type 2 diabetes, cardiovascular disease, cardiovascular risk, lipids, glucose, metabolic syndrome, A1C, intima-media thickness, thiazolidinediones, pioglitazone, rosiglitazone, glimepiride, metformin, TZDs, glyburide, DREAM trial, CHICAGO trial PeerView Press Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA03563FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA03563FCCMEinfo.pdf Thu, 08 Mar 2007 16:29:44 -0500 Science no 00:00:00 diabetes, type 2 diabetes, cardiovascular disease, cardiovascular risk, lipids, glucose, metabolic syndrome, A1C, intima-media thickness, thiazolidinediones, pioglitazone, rosiglitazone, glimepiride, metformin, TZDs, glyburide, DREAM trial, CHICAGO trial PeerView Press Please be sure to view the accompanying (PDF) file or full CME/CE information. In this activity, experts in the treatment of diabetes present recent data on the efficacy and safety of bile acid sequestrants when used in patients with type 2 diabetes who are not adequately controlled with their current antidiabetic medication regimens. Bile acid metabolism and the role of bile acids in diabetes and cardiovascular disease are also discussed. http://podcast.peerviewpress.com/Endocrinology/PA03436FCendjun06a.mp3 http://podcast.peerviewpress.com/endocrinology/PA03436FCendjun06a.mp3 Fri, 22 Sep 2006 12:25:00 -0400 Science no 00:17:36 diabetes, bile acids, bile acid sequestrants, type 2 diabetes, LDL cholesterol, total cholesterol, cholestyramine, colestipol, colesevelam HCl, colestimide, cardiovascular disease, Hb A1C, sulfonylurea, metformin, glycemic control, postprandial glucose PeerView Press Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA03436FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA03436FCCMEinfo.pdf Fri, 22 Sep 2006 12:24:35 -0400 Science no 00:00:00 diabetes, bile acids, bile acid sequestrants, type 2 diabetes, LDL cholesterol, total cholesterol, cholestyramine, colestipol, colesevelam HCl, colestimide, cardiovascular disease, Hb A1C, sulfonylurea, metformin, glycemic control, postprandial glucose PeerView Press Please be sure to view the accompanying (PDF) file or full CME/CE information. Improving Outcomes in Male Hypogonadism: Detection and Treatment Strategies http://podcast.peerviewpress.com/Endocrinology/PA03289FCinR192.mp3 http://podcast.peerviewpress.com/endocrinology/PA03289FCinR192.mp3 Thu, 27 Jul 2006 16:53:16 -0400 Science no 00:21:30 Male hypogonadism, testosterone, testosterone replacement therapy, TRT, delivery systems, transdermal patches, buccal system, testosterone gel, intramuscular injections, subcutaneous pellets, metabolic syndrome, obesity, type 2 diabetes, oral testosterone PeerView Press Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA03289FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PAO3289FCCMEinfo.pdf Thu, 27 Jul 2006 16:53:11 -0400 Science no 00:00:00 Male hypogonadism, testosterone, testosterone replacement therapy, TRT, delivery systems, transdermal patches, buccal system, testosterone gel, intramuscular injections, subcutaneous pellets, metabolic syndrome, obesity, type 2 diabetes, oral testosterone PeerView Press Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of diabetes present the most current data on treatment goals in type 2 diabetes. The implications of postprandial hyperglycemia, preservation of beta cell function, and treatment-related weight effects on overall glycemic control will be discussed, as will new and emerging treatment options that may improve the ability of patients to achieve appropriate treatment goals. http://podcast.peerviewpress.com/endocrinology/PA03010FCinR176.mp3 1 Mon, 22 May 2006 12:00:00 -0400 Science no 00:21:51 type 2 diabetes, postprandial Hb A1C, hyperglycemia treatment goals, beta cell function, Eli Lilly, insulin, byetta, humalog, humulin, ADA, AACE, mellitus, metformin, glycemic control options, inhaled, ruboxistaurin, exenatide, pramlintide PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/endocrinology/PA03010FCCMEinfo.pdf 2 Mon, 22 May 2006 12:00:00 -0400 Science no 00:00:00 type 2 diabetes, postprandial Hb A1C, hyperglycemia treatment goals, beta cell function, Eli Lilly, insulin, byetta, humalog, humulin, ADA, AACE, mellitus, metformin, glycemic control options, inhaled, ruboxistaurin, exenatide, pramlintide